Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus
Status epilepticus (SE), a medical emergency that is typically terminated through antiepileptic drug treatment, leads to hippocampus dysfunction typified by neurodegeneration, inflammation, altered neurogenesis, as well as cognitive and memory deficits. Here, we examined the effects of intranasal (IN) administration of extracellular vesicles (EVs) secreted from human bone marrow-derived mesenchymal stem cells (MSCs) on SE-induced adverse changes. The EVs used in this study are referred to as A1-exosomes because of their robust antiinflammatory properties. We subjected young mice to pilocarpine-induced SE for 2 h and then administered A1-exosomes or vehicle IN twice over 24 h. The A1-exosomes reached the hippocampus within 6 h of administration, and animals receiving them exhibited diminished loss of glutamatergic and GABAergic neurons and greatly reduced inflammation in the hippocampus. Moreover, the neuroprotective and antiinflammatory effects of A1-exosomes were coupled with long-term preservation of normal hippocampal neurogenesis and cognitive and memory function, in contrast to waned and abnormal neurogenesis, persistent inflammation, and functional deficits in animals receiving vehicle. These results provide evidence that IN administration of A1-exosomes is efficient for minimizing the adverse effects of SE in the hippocampus and preventing SE-induced cognitive and memory impairments..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
---|---|
Enthalten in: |
Proceedings of the National Academy of Sciences of the United States of America - 114(2017), 17, Seite E3536 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Qianfa Long [VerfasserIn] |
---|
Links: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1995552348 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1995552348 | ||
003 | DE-627 | ||
005 | 20230715062527.0 | ||
007 | tu | ||
008 | 170721s2017 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20170901 |
035 | |a (DE-627)OLC1995552348 | ||
035 | |a (DE-599)GBVOLC1995552348 | ||
035 | |a (PRQ)p939-2ce0f4509d3d3cb5e7eef2287437447e7cb6e224ccff4b39e38e34a5591cc60e0 | ||
035 | |a (KEY)0583363920170000114001703536intranasalmscderiveda1exosomeseaseinflammationandp | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 500 |q DE-101 |
082 | 0 | 4 | |a 570 |q AVZ |
084 | |a LING |2 fid | ||
084 | |a BIODIV |2 fid | ||
100 | 0 | |a Qianfa Long |e verfasserin |4 aut | |
245 | 1 | 0 | |a Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Status epilepticus (SE), a medical emergency that is typically terminated through antiepileptic drug treatment, leads to hippocampus dysfunction typified by neurodegeneration, inflammation, altered neurogenesis, as well as cognitive and memory deficits. Here, we examined the effects of intranasal (IN) administration of extracellular vesicles (EVs) secreted from human bone marrow-derived mesenchymal stem cells (MSCs) on SE-induced adverse changes. The EVs used in this study are referred to as A1-exosomes because of their robust antiinflammatory properties. We subjected young mice to pilocarpine-induced SE for 2 h and then administered A1-exosomes or vehicle IN twice over 24 h. The A1-exosomes reached the hippocampus within 6 h of administration, and animals receiving them exhibited diminished loss of glutamatergic and GABAergic neurons and greatly reduced inflammation in the hippocampus. Moreover, the neuroprotective and antiinflammatory effects of A1-exosomes were coupled with long-term preservation of normal hippocampal neurogenesis and cognitive and memory function, in contrast to waned and abnormal neurogenesis, persistent inflammation, and functional deficits in animals receiving vehicle. These results provide evidence that IN administration of A1-exosomes is efficient for minimizing the adverse effects of SE in the hippocampus and preventing SE-induced cognitive and memory impairments. | ||
650 | 4 | |a Animals | |
650 | 4 | |a Hippocampus | |
650 | 4 | |a Animal cognition | |
650 | 4 | |a Bone marrow | |
650 | 4 | |a Brain | |
650 | 4 | |a Neuroprotection | |
650 | 4 | |a Mice | |
650 | 4 | |a Neurodegeneration | |
650 | 4 | |a Animal memory | |
650 | 4 | |a Receiving | |
650 | 4 | |a Neurogenesis | |
650 | 4 | |a Stem cells | |
650 | 4 | |a Glutamatergic transmission | |
650 | 4 | |a Stem cell transplantation | |
650 | 4 | |a Cognitive ability | |
650 | 4 | |a Epilepsy | |
650 | 4 | |a Neurons | |
650 | 4 | |a γ-Aminobutyric acid | |
650 | 4 | |a Pilocarpine | |
650 | 4 | |a Preservation | |
650 | 4 | |a Mesenchyme | |
650 | 4 | |a Side effects | |
650 | 4 | |a Emergency medical services | |
650 | 4 | |a Exosomes | |
700 | 0 | |a Dinesh Upadhya |4 oth | |
700 | 0 | |a Bharathi Hattiangady |4 oth | |
700 | 0 | |a Dong-Ki Kim |4 oth | |
700 | 0 | |a Su Yeon An |4 oth | |
700 | 0 | |a Bing Shuai |4 oth | |
700 | 0 | |a Darwin J Prockop |4 oth | |
700 | 0 | |a Ashok K Shetty |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Proceedings of the National Academy of Sciences of the United States of America |d Washington, DC : NAS, 1877 |g 114(2017), 17, Seite E3536 |w (DE-627)129505269 |w (DE-600)209104-5 |w (DE-576)014909189 |x 0027-8424 |7 nnns |
773 | 1 | 8 | |g volume:114 |g year:2017 |g number:17 |g pages:E3536 |
856 | 4 | 2 | |u https://search.proquest.com/docview/1902095503 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-LING | ||
912 | |a FID-BIODIV | ||
912 | |a SSG-OLC-PHY | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-MAT | ||
912 | |a SSG-OLC-FOR | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-MAT | ||
912 | |a SSG-OPC-FOR | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_59 | ||
951 | |a AR | ||
952 | |d 114 |j 2017 |e 17 |h E3536 |